Trials / Not Yet Recruiting
Not Yet RecruitingNCT07088484
Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma
Watch-and-Wait Strategy in Patients With Objective Response After Immuno-chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma: A Prospective Multicenter Observational Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Fujian Cancer Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare chemotherapy plus immunotherapy with immunochemotherapy combined subsequent locoregional radiotherapy in recurrent nasopharyngeal carcinoma (NPC), in order to confirm the value of immunotherapy and chemotherapy in recurrent NPC patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ICI-chemotherapy and LIMT | gemcitabine, docetaxel, paclitaxel, cisplatin, platinum, capecitabine, S1; Tislelizumab. |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2027-09-01
- Completion
- 2027-09-01
- First posted
- 2025-07-28
- Last updated
- 2025-07-28
Source: ClinicalTrials.gov record NCT07088484. Inclusion in this directory is not an endorsement.